Stacey Boyer PhD, CCRP

Dr. Boyer is an experienced biotech and pharma R&D executive leading translational through late-stage clinical development in multiple CNS indications. Presently, Dr. Boyer is the Vice President of Clinical Research Operations at Cavion, Inc., a clinical-stage pharmaceutical company developing first-in-class therapies which modulate overactive T-type channels. Prior to, Dr. Boyer concentrated in strategy and operations at Takeda Pharmaceuticals, Biogen, and Pfizer. Dr. Boyer holds Clinical Research Professional and National Institutes of Health certifications and actively contributes to the CNS field via numerous peer-reviewed publications.